282 15. Boettiger CA, D’Esposito M. Frontal Networks for Learning and Executing Arbitrary Stimulus-Response Associations. J Neurosci. 2005;25(10):2723-2732. doi:10.1523/JNEUROSCI.3697-04.2005 16. Brincat SL, Miller EK. Frequency-specific hippocampal-prefrontal interactions during associative learning. Nature Neuroscience. 2015;18(4):576-581. doi:10.1038/nn.3954 17. Zhong W, Gold J, Marzen S, England J, Halpern N. Machine learning outperforms thermodynamics in measuring how well a many-body system learns a drive. Scientific Reports. 2021;11. doi:10.1038/s41598-021-88311-7 18. McClelland JL, McNaughton BL, O’Reilly RC. Why there are complementary learning systems in the hippocampus and neocortex: Insights from the successes and failures of connectionist models of learning and memory. Psychological Review. 1995;102(3):419-457. doi:10.1037/0033-295X.102.3.419 19. Rezvani AH. Involvement of the NMDA System in Learning and Memory. CRC Press/Taylor & Francis; 2006. http://www.ncbi.nlm.nih.gov/pubmed/21204373 20. Albu S, Meagher MW. Expectation of nocebo hyperalgesia affects EEG alphaactivity. International Journal of Psychophysiology. 2016;109:147-152. doi:10.1016/j.ijpsycho.2016.08.009 21. Bartels DJP, van Laarhoven AIM, Stroo M, et al. Minimizing nocebo effects by conditioning with verbal suggestion: A randomized clinical trial in healthy humans. Darragh M, ed. PLOS ONE. 2017;12(9):e0182959-e0182959. doi:10.1371/journal.pone.0182959 22. Bartels DJP, van Laarhoven AIM, Haverkamp EA, et al. Role of Conditioning and Verbal Suggestion in Placebo and Nocebo Effects on Itch. Sakakibara M, ed. PLoS ONE. 2014;9(3):e91727-e91727. doi:10.1371/journal.pone.0091727 23. Colagiuri B, Quinn VF. Autonomic Arousal as a Mechanism of the Persistence of Nocebo Hyperalgesia. The journal of pain : official journal of the American Pain Society. 2018;19(5):476-486. doi:10.1016/j.jpain.2017.12.006 24. Colagiuri B, Quinn VF, Colloca L. Nocebo Hyperalgesia, Partial Reinforcement, and Extinction. The Journal of Pain. 2015;16(10):995-1004. doi:10.1016/J.JPAIN.2015.06.012 25. Manaï M, van Middendorp H, Veldhuijzen DS, Huizinga TWJ, Evers AWM. How to prevent, minimize, or extinguish nocebo effects in pain. PAIN Reports. 2019;4(3):e699-e699. doi:10.1097/PR9.0000000000000699 26. Colloca L. Placebo- and nocebo-induced pain modulation: from bedside to bench and back to bedside. Douleur et Analgésie. 2014;27(4):203-209. doi:10.1007/s11724014-0401-4 27. Colloca L, Grillon C. Understanding placebo and nocebo responses for pain management. Current Pain and Headache Reports. 2014;18(6):419-419. doi:10.1007/s11916014-0419-2 28. Napadow V, Li A, Loggia ML, et al. The imagined itch: Brain circuitry supporting nocebo-induced itch in atopic dermatitis patients. Allergy: European Journal of Allergy and Clinical Immunology. 2015;70:1485-1492-1485-1492. doi:10.1111/all.12727 29. Elsenbruch S, Rosenberger C, Bingel U, Forsting M, Schedlowski M, Gizewski ER. Patients With Irritable Bowel Syndrome Have Altered Emotional Modulation of Neural Responses to Visceral Stimuli. Gastroenterology. 2010;139(4):1310-1319.e4. doi:10.1053/j.gastro.2010.06.054 30. Benedetti F, Amanzio M, Vighetti S, Asteggiano G. The Biochemical and Neuroendocrine Bases of the Hyperalgesic Nocebo Effect. Journal of Neuroscience. 2006;26(46):12014-12022. doi:10.1523/JNEUROSCI.2947-06.2006
RkJQdWJsaXNoZXIy MTk4NDMw